Aurinia Pharmaceuticals to Present at Upcoming 41st Annual J.P. Morgan Healthcare Conference Pharmaceutical Investing
Gilead Sciences: Connecting Breast Cancer Education to Community: Equal Hope Pharmaceutical Investing
Aurinia Announces LUPKYNIS® Patent Challenge Settlement Reached With Sun Pharmaceuticals Pharmaceutical Investing
European Medicines Agency Validates Marketing Authorization Application For Trodelvy® For Pre-treated HR+/HER2- Metastatic Breast Cancer Pharmaceutical Investing
Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies Pharmaceutical Investing
Bristol Myers Squibb to Present at J.P. Morgan's 41st Annual Healthcare Conference Pharmaceutical Investing
Bristol Myers Squibb Completes Sale of Manufacturing Facility in Syracuse, New York Pharmaceutical Investing
Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate Life Science Investing
U.S. FDA Accepts for Review the Biologics License Application for Pfizer's Investigational Pentavalent Meningococcal Vaccine Candidate in Adolescents Life Science Investing
